Chary AN, Naik AD, Kennedy M Reply to: Expanding options to include language barriers for predicting postoperative delirium in geriatric patients. J Am Geriatr Soc. 2023 Jan;71(1):294-295. doi: 10.1111/jgs.18083. Epub 2022 Oct 17. No abstract available.
Dindo L, Chaison A, Rodrigues M, Woods K, Mark A, Boykin D Feasibility of delivering a virtual 1-day acceptance and commitment therapy workshop to rural veterans through community partnerships. Contemp Clin Trials Commun. 2023 Jun 20;34:101178. doi: 10.1
Fried TR Giving up on the objective of providing goal-concordant care: Advance care planning for improving caregiver outcomes. J Am Geriatr Soc. 2022 Oct;70(10):3006-3011. doi: 10.1111/jgs.18000. Epub 2022 Aug 16.
Naik AD, Walling AM Getting patients ready for "in the moment" decisions. J Am Geriatr Soc. 2022 Sep;70(9):2474-2477. doi: 10.1111/jgs.17935. Epub 2022 Jul 4. No abstract available.
Naik AD Measuring patient-centered care to improve hospital experiences of older adults. J Am Geriatr Soc. 2022 Dec;70(12):3348-3351. doi: 10.1111/jgs.18048. Epub 2022 Sep 20. No abstract available.
Scholle SH, Naik AD A Person-Centered Care Dashboard for Individuals With Complex Health Care Needs-Charting a Course for the Future. JAMA Netw Open. 2022 Aug 1;5(8):e2224945. doi: 10.1001/jamanetworkopen.2022.24945. No abstract available.
Zang E, Shi Y, Wang X, Wu B, Fried TR Trajectories of physical functioning among US adults with cognitive impairment. Age Ageing. 2022 Jun 1;51(6):afac139. doi: 10.1093/ageing/afac139.
Effect of Patient Priorities Care Implementation in Older Veterans With Multiple Chronic Conditions
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
